Could a simple pain shot improve IVF recovery without hurting success?
NCT ID NCT07185724
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving the painkiller ketorolac after egg retrieval can safely reduce pain without lowering the chance of pregnancy in fresh embryo transfers. About 200 IVF patients will be randomly assigned to receive either ketorolac or no ketorolac after their egg retrieval. The researchers will compare implantation rates, pain levels, and live birth rates between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ketorolac (a nonsteroidal anti-inflammatory drug given by IV)
What this could lead to
If it works, this could show that ketorolac is a safe and effective painkiller for women having fresh embryo transfers after egg retrieval.
What could go wrong
This is a single, mid-sized trial. Earlier studies were mixed, and there is still a theoretical risk that ketorolac could affect implantation or increase bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY (IVF PATIENTS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UI Health Care Center for Advanced Reproductive Care
RECRUITINGIowa City, Iowa, 52245, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact